4.7 Article

Integrin-αvβ3 regulates thrombopoietin-mediated maintenance of hematopoietic stem cells

期刊

BLOOD
卷 119, 期 1, 页码 83-94

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-02-335430

关键词

-

资金

  1. Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology Cell Sheet Tissue Engineering Center
  2. KIBAN
  3. Ministry of Education, Culture, Sports, Science and Technology, Japan
  4. Mitsubishi Pharma Foundation
  5. National Institutes of Health [HL078784 RO1]
  6. Grants-in-Aid for Scientific Research [23659514, 21390321, 21300160] Funding Source: KAKEN

向作者/读者索取更多资源

Throughout life, one's blood supply depends on sustained division of hematopoietic stem cells (HSCs) for self-renewal and differentiation. Within the bone marrow microenvironment, an adhesiondependent or -independent niche system regulates HSC function. Here we show that a novel adhesion-dependent mechanism via integrin-beta 3 signaling contributes to HSC maintenance. Specific ligation of beta 3-integrin on HSCs using an antibody or extracellular matrix protein prevented loss of long-term repopulating (LTR) activity during ex vivo culture. The actions required activation of alpha v beta 3-integrin inside-out signaling, which is dependent on thrombopoietin (TPO), an essential cytokine for activation of dormant HSCs. Subsequent outside-in signaling via phosphorylation of Tyr747 in the beta 3-subunit cytoplasmic domain was indispensable for TPO-dependent, but not stem cell factor-dependent, LTR activity in HSCs in vivo. This was accompanied with enhanced expression of Vps72, Mll1, and Runx1, 3 factors known to be critical for maintaining HSC activity. Thus, our findings demonstrate a mechanistic link between beta 3-integrin and TPO in HSCs, which may contribute to maintenance of LTR activity in vivo as well as during ex vivo culture. (Blood. 2012; 119(1): 83-94)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Ophthalmology

Atypical indocyanine green angiography findings after indocyanine green assisted internal limiting membrane peeling

Yumi Noguchi, Tatsuhiko Sato, Miho Kumoi, Noriyasu Hashida, Kohji Nishida

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2018)

Article Hematology

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

Jun Ishihara, Ako Ishihara, Richard D. Starke, Claire R. Peghaire, Koval E. Smith, Thomas A. J. McKinnon, Yoji Tabata, Koichi Sasaki, Michael J. V. White, Kazuto Fukunaga, Mike A. Laffan, Matthias P. Lutolf, Anna M. Randi, Jeffrey A. Hubbell

Meeting Abstract Oncology

Collagen affinity improves efficacy and safety of antibody and cytokine cancer immunotherapy.

Ako Ishihara, Jun Ishihara, Jeffrey A. Hubbell, Melody A. Swartz

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Cell Biology

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M. Raczy, Laura T. Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J. Kron, Melody A. Swartz, Jeffrey A. Hubbell

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy

Koichi Sasaki, Jun Ishihara, Ako Ishihara, Risako Miura, Aslan Mansurov, Kazuto Fukunaga, Jeffrey A. Hubbell

SCIENCE ADVANCES (2019)

Article Multidisciplinary Sciences

Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies

Kiyomitsu Katsumata, Jun Ishihara, Aslan Mansurov, Ako Ishihara, Michal M. Raczy, Eiji Yuba, Jeffrey A. Hubbell

SCIENCE ADVANCES (2019)

Article Multidisciplinary Sciences

Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy

John-Michael Williford, Jun Ishihara, Ako Ishihara, Aslan Mansurov, Peyman Hosseinchi, Tiffany M. Marchell, Lambert Potin, Melody A. Swartz, Jeffrey A. Hubbell

SCIENCE ADVANCES (2019)

Article Engineering, Biomedical

Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis

Ako Ishihara, Jun Ishihara, Elyse A. Watkins, Andrew C. Tremain, Mindy Nguyen, Ani Solanki, Kiyomitsu Katsumata, Aslan Mansurov, Erica Budina, Aaron T. Alpar, Peyman Hosseinchi, Lea Maillat, Joseph W. Reda, Takahiro Kageyama, Melody A. Swartz, Eiji Yuba, Jeffrey A. Hubbell

Summary: The SA-IL-4 fusion protein effectively prevents disease development in mice with EAE by reducing spinal cord infiltration of immune cells, decreasing integrin expression in antigen-specific CD4(+)T cells, increasing the number of granulocyte-like myeloid-derived suppressor cells, and decreasing the number of pathogenic T helper 17 cells.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Rheumatology

Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models

Eiji Yuba, Erica Budina, Kiyomitsu Katsumata, Ako Ishihara, Aslan Mansurov, Aaron T. Alpar, Elyse A. Watkins, Peyman Hosseinchi, Joseph W. Reda, Abigail L. Lauterbach, Mindy Nguyen, Ani Solanki, Takahiro Kageyama, Melody A. Swartz, Jun Ishihara, Jeffrey A. Hubbell

Summary: Fusion of IL-10 with serum albumin increases its accumulation in lymph nodes and shows promising therapeutic effects in murine models of arthritis. Treatment with SA-IL-10 restores immune cell composition and reduces inflammatory factors, protecting joint morphology effectively.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Multidisciplinary Sciences

Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas

Maria Stella Sasso, Nikolaos Mitrousis, Yue Wang, Priscilla S. Briquez, Sylvie Hauert, Jun Ishihara, Jeffrey A. Hubbell, Melody A. Swartz

Summary: The induction of lymphatic growth in melanoma has been linked to poor prognosis, but recent research has shown that it can enhance cancer immunotherapy and boost T cell immunity. Developing a translational approach, the study found that inducing lymphangiogenesis in cancer vaccines can lead to stronger T cell activation and higher frequencies of antigen-specific T cells, ultimately providing effective tumor control and long-term immunological memory in mouse melanoma models.

SCIENCE ADVANCES (2021)

Article Cell Biology

Immunoengineering approaches for cytokine therapy

Aslan Mansurov, Abigail Lauterbach, Erica Budina, Aaron T. Alpar, Jeffrey A. Hubbell, Jun Ishihara

Summary: Efforts to achieve therapeutic translation of cytokines for treating diseases such as cancer and autoimmune diseases have been hindered by the unfavorable pharmacokinetic and pharmacodynamic profiles of wild-type cytokines, leading to challenging toxicity profiles and limited therapeutic efficacy. Further research and development in protein-engineering approaches are needed to address these limitations and enhance the therapeutic indices of cytokines for more effective treatment.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Article Engineering, Biomedical

Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker

Aslan Mansurov, Peyman Hosseinchi, Kevin Chang, Abigail L. Lauterbach, Laura T. Gray, Aaron T. Alpar, Erica Budina, Anna J. Slezak, Seounghun Kang, Shijie Cao, Ani Solanki, Suzana Gomes, John-Michael Williford, Melody A. Swartz, Juan L. Mendoza, Jun Ishihara, Jeffrey A. Hubbell

Summary: Fusing a domain of the IL-12 receptor to IL-12 via a linker cleavable by tumour-associated proteases can restrict the pro-inflammatory effects of IL-12 to tumour sites, eliminating systemic immune-related adverse events and triggering potent therapeutic effects in mice bearing immunologically cold tumours.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Immunology

Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021

Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Kyuto Tanaka, Eiyu Matsumoto, Kenta Horimukai, Jun Ishihara, Shugo Sasaki, Kanako Inaba, Kyosuke Seguchi, Hiromizu Takahashi, Jorge L. Salinas, Yuji Yamada

Summary: A study found that the use of mobile messenger apps can reduce vaccine hesitancy among users. The survey results showed that vaccine hesitancy decreased from 41% to 20% after using Corowa-kun. Factors such as age, gender, and previous vaccine side effects were found to be associated with vaccine hesitancy.

VACCINE (2022)

Review Materials Science, Biomaterials

Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy

Srinivas Balagopal, Koichi Sasaki, Pooja Kaur, Maria Nikolaidi, Jun Ishihara

Summary: CAR-T cell therapy has shown remarkable efficacy against hematological malignancies, but often leads to cytokine release syndrome. New approaches are being developed to control cytokine production and reduce the risk of this adverse event.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Letter Ophthalmology

Prominent regression of corneal deposits in Fabry disease 16years after initiation of enzyme replacement therapy

Shizuka Koh, Norio Sakai, Naoyuki Maeda, Kohji Nishida

ACTA OPHTHALMOLOGICA (2018)

暂无数据